149 related articles for article (PubMed ID: 30393149)
1. Development and pre-validation of a quantitative multi-dose serological assay for potency testing of inactivated rabies vaccines for human use.
Moreira WC; Freitas JFS; Machado NS; Almeida AECC; Moura WC
J Virol Methods; 2019 Jan; 263():54-59. PubMed ID: 30393149
[TBL] [Abstract][Full Text] [Related]
2. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
[TBL] [Abstract][Full Text] [Related]
3. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
4. Possibility of Immediate Introduction of a Single-Dose Antibody Induction Test as a Refinement of the NIH Test for Inactivated Rabies Vaccine Potency Determination.
Stankov S; Obradović N; Vujin D; Vranješ N
Viral Immunol; 2020 Jun; 33(5):367-377. PubMed ID: 32159457
[TBL] [Abstract][Full Text] [Related]
5. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
6. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
[TBL] [Abstract][Full Text] [Related]
7. Potency testing of inactivated rabies vaccines using a serological method.
Kamphuis E; Krämer B; Schildger H; Duchow K
Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
[TBL] [Abstract][Full Text] [Related]
8. A step forward in the quality control testing of inactivated rabies vaccines - extensive evaluation of European vaccines by using alternative methods to the in vivo potency tests.
Servat A; Kempff S; Brogat V; Litaize E; Schereffer JL; Cliquet F
Altern Lab Anim; 2015 Mar; 43(1):19-27. PubMed ID: 25802995
[TBL] [Abstract][Full Text] [Related]
9. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
Smith TG; Ellison JA; Ma X; Kuzmina N; Carson WC; Rupprecht CE
Vaccine; 2013 Jul; 31(33):3333-8. PubMed ID: 23742991
[TBL] [Abstract][Full Text] [Related]
10. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
Liu Y; Zhang S; Zhang F; Hu R
Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
[TBL] [Abstract][Full Text] [Related]
11. Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA.
Toinon A; Moreno N; Chausse H; Mas E; Nicolai MC; Guinchard F; Jaudinaud I; Guinet-Morlot F; Riou P; Manin C
Biologicals; 2019 Jul; 60():49-54. PubMed ID: 31105021
[TBL] [Abstract][Full Text] [Related]
12. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
[TBL] [Abstract][Full Text] [Related]
14. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
[TBL] [Abstract][Full Text] [Related]
15. Thermotolerance of an inactivated rabies vaccine for dogs.
Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
[TBL] [Abstract][Full Text] [Related]
16. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use.
Krämer B; Bruckner L; Daas A; Milne C
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):37-55. PubMed ID: 21144488
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
[TBL] [Abstract][Full Text] [Related]
18. In vitro potency tests: challenges encountered during method development.
Yomayuza CL; Thiel HJ; König M
Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
[TBL] [Abstract][Full Text] [Related]
19. Development of a relative potency test using ELISA for human rabies vaccines.
Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
[TBL] [Abstract][Full Text] [Related]
20. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
